Handling drug patent opposition proceedings is a crucial step in ensuring the quality and validity of granted patents in the […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization. Patents must be filed in each […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Ireland. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Ireland? Read Post »
Annual Drug Patent Expirations for DSUVIA Dsuvia is a drug marketed by Vertical Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. […]
Source
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. […]
Source
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New […]
Source
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
Get new actionable insights and updates from BiotechBlog
